Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Colorcon
Dow
US Department of Justice
McKinsey
Cerilliant
UBS
Fish and Richardson
Johnson and Johnson

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,037,845

« Back to Dashboard

Summary for Patent: 5,037,845
Title: Indole derivative
Abstract:A compound of formula (I) ##STR1## and its physiologically acceptable salts and solvates are described as useful in treating and/or preventing pain resulting from dilatation of the cranial vasculature in particular migraine. The compound (I) may be prepared, for example, by cyclizing a compound of formula (II) ##STR2##
Inventor(s): Oxford; Alexander W. (Royston, GB2)
Assignee: Glaxo Group Limited (GB2)
Application Number:07/317,682
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Dosage form;

Drugs Protected by US Patent 5,037,845

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,037,845

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8419575Aug 01, 1984

International Patents Family Members for US Patent 5,037,845

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 386196 ➤ Try a Free Trial
Austria A226685 ➤ Try a Free Trial
Australia 4568985 ➤ Try a Free Trial
Australia 573878 ➤ Try a Free Trial
Belgium 903006 ➤ Try a Free Trial
Canada 1241004 ➤ Try a Free Trial
Switzerland 666026 ➤ Try a Free Trial
Cyprus 1475 ➤ Try a Free Trial
Czech Republic 280530 ➤ Try a Free Trial
Czech Republic 9104041 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
McKinsey
Cantor Fitzgerald
Medtronic
US Department of Justice
Julphar
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot